{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:12:29Z","timestamp":1778191949687,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["24JCQNJC00860"],"award-info":[{"award-number":["24JCQNJC00860"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["23JCYBJC00600"],"award-info":[{"award-number":["23JCYBJC00600"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472991"],"award-info":[{"award-number":["82472991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203423"],"award-info":[{"award-number":["82203423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373365"],"award-info":[{"award-number":["82373365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403771"],"award-info":[{"award-number":["82403771"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds of the Natural Science Foundation Tianjin","award":["No.25JCLMJC00720"],"award-info":[{"award-number":["No.25JCLMJC00720"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752393"],"award-info":[{"award-number":["2024M752393"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Tianjin Binhai New Area health commission","award":["2023BWKQ016"],"award-info":[{"award-number":["2023BWKQ016"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15911-9","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:06:20Z","timestamp":1774677980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A lactylation-associated gene signature predicts prognosis in neuroblastoma and identifies RPS6KA6 as a candidate biomarker"],"prefix":"10.1186","volume":"26","author":[{"given":"Lin","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benfu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuren","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"8","key":"15911_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","volume":"19","author":"B Qiu","year":"2022","unstructured":"Qiu B, Matthay KK. Advancing therapy for neuroblastoma. Nat Rev Clin Oncol. 2022;19(8):515\u201333.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"15911_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/med.21750","volume":"41","author":"A Zafar","year":"2021","unstructured":"Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, et al. Molecular targeting therapies for neuroblastoma: Progress and challenges. Med Res Rev. 2021;41(2):961\u20131021.","journal-title":"Med Res Rev"},{"issue":"4","key":"15911_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41588-018-0044-9","volume":"50","author":"R Zeid","year":"2018","unstructured":"Zeid R, Lawlor MA, Poon E, Reyes JM, Fulciniti M, Lopez MA, et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat Genet. 2018;50(4):515\u201323.","journal-title":"Nat Genet"},{"issue":"17","key":"15911_CR4","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1200\/JCO.19.03285","volume":"38","author":"E Sokol","year":"2020","unstructured":"Sokol E, Desai AV, Applebaum MA, Valteau-Couanet D, Park JR, Pearson ADJ, et al. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project. J Clin Oncol. 2020;38(17):1906\u201318.","journal-title":"J Clin Oncol"},{"issue":"17","key":"15911_CR5","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1200\/JCO.22.01946","volume":"41","author":"HG Bender","year":"2023","unstructured":"Bender HG, Irwin MS, Hogarty MD, Castleberry R, Maris JM, Kao PC, et al. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children\u2019s Oncology Group Risk Stratification. J Clin Oncol. 2023;41(17):3149\u201359.","journal-title":"J Clin Oncol"},{"issue":"7779","key":"15911_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"key":"15911_CR7","doi-asserted-by":"publisher","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","volume":"590","author":"S Chen","year":"2024","unstructured":"Chen S, Xu Y, Zhuo W, Zhang L. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett. 2024;590:216837.","journal-title":"Cancer Lett"},{"key":"15911_CR8","doi-asserted-by":"crossref","unstructured":"Cheng Z, Huang H, Li M, Liang X, Tan Y, Chen Y. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma. Pharmaceuticals (Basel). 2023;16(5):644.","DOI":"10.3390\/ph16050644"},{"issue":"2","key":"15911_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 2018;173(2):338\u2013. \u2013\u200954.e15.","journal-title":"Cell"},{"issue":"5","key":"15911_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"issue":"7","key":"15911_CR11","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"30","key":"15911_CR12","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med"},{"issue":"6","key":"15911_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators. Eur Urol. 2018;74(6):796\u2013804.","journal-title":"Eur Urol"},{"key":"15911_CR14","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1","key":"15911_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"5","key":"15911_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.stem.2021.01.015","volume":"28","author":"MK Bin Imtiaz","year":"2021","unstructured":"Bin Imtiaz MK, Jaeger BN, Bottes S, Machado RAC, Vidmar M, Moore DL, et al. Declining lamin B1 expression mediates age-dependent decreases of hippocampal stem cell activity. Cell Stem Cell. 2021;28(5):967\u2013e778.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"15911_CR17","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"15911_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"15911_CR19","doi-asserted-by":"crossref","unstructured":"Zhao Y, Chen X, Chen J, Qi X. Decoding Connectivity Map-based drug repurposing for oncotherapy. Brief Bioinform. 2023;24(3):bbad142.","DOI":"10.1093\/bib\/bbad142"},{"issue":"1","key":"15911_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"15911_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330.","journal-title":"Autophagy"},{"issue":"5","key":"15911_CR22","doi-asserted-by":"publisher","first-page":"152394","DOI":"10.1016\/j.seminoncol.2025.152394","volume":"52","author":"C Zhu","year":"2025","unstructured":"Zhu C, Tian M, Di X, Liu J, Chen H, Xu L, et al. Lactylation in radiosensitivity regulation: Mechanistic insights and recent advances. Semin Oncol. 2025;52(5):152394.","journal-title":"Semin Oncol"},{"issue":"10","key":"15911_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrn.2016.92","volume":"17","author":"I P\u00e9rez-Ota\u00f1o","year":"2016","unstructured":"P\u00e9rez-Ota\u00f1o I, Larsen RS, Wesseling JF. Emerging roles of GluN3-containing NMDA receptors in the CNS. Nat Rev Neurosci. 2016;17(10):623\u201335.","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"15911_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41419-021-04027-6","volume":"12","author":"H Lei","year":"2021","unstructured":"Lei H, Wang Z, Jiang D, Liu F, Liu M, Lei X, et al. CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer. Cell Death Dis. 2021;12(8):740.","journal-title":"Cell Death Dis"},{"key":"15911_CR25","doi-asserted-by":"publisher","first-page":"101023","DOI":"10.1016\/j.neo.2024.101023","volume":"55","author":"M Bogaard","year":"2024","unstructured":"Bogaard M, Str\u00f8mme JM, Kidd SG, Johannessen B, Bakken AC, Lothe RA, et al. GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer. Neoplasia. 2024;55:101023.","journal-title":"Neoplasia"},{"issue":"6122","key":"15911_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339(6122):959\u201361.","journal-title":"Science"},{"issue":"1","key":"15911_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-024-06454-7","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Zhang Y, Jian Y, Gu L, Zhang D, Zhou H, et al. The regulations of telomerase reverse transcriptase (TERT) in cancer. Cell Death Dis. 2024;15(1):90.","journal-title":"Cell Death Dis"},{"issue":"11","key":"15911_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1507\/endocrj.EJ23-0136","volume":"70","author":"M Matsuse","year":"2023","unstructured":"Matsuse M, Mitsutake N. TERT promoter mutations in thyroid cancer. Endocr J. 2023;70(11):1035\u201349.","journal-title":"Endocr J"},{"issue":"2","key":"15911_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-021-02337-9","volume":"142","author":"K Fujimoto","year":"2021","unstructured":"Fujimoto K, Arita H, Satomi K, Yamasaki K, Matsushita Y, Nakamura T, et al. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol. 2021;142(2):323\u201338.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"15911_CR30","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s41467-020-15289-7","volume":"11","author":"M Yasukawa","year":"2020","unstructured":"Yasukawa M, Ando Y, Yamashita T, Matsuda Y, Shoji S, Morioka MS, et al. CDK1 dependent phosphorylation of hTERT contributes to cancer progression. Nat Commun. 2020;11(1):1557.","journal-title":"Nat Commun"},{"issue":"1","key":"15911_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41375-019-0522-9","volume":"34","author":"H Wang","year":"2020","unstructured":"Wang H, Zhao D, Nguyen LX, Wu H, Li L, Dong D, et al. Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia. Leukemia. 2020;34(1):75\u201386.","journal-title":"Leukemia"},{"issue":"19","key":"15911_CR32","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1042\/BCJ20200359","volume":"477","author":"S Sanyal","year":"2020","unstructured":"Sanyal S, Mondal P, Sen S, Sengupta Bandyopadhyay S, Das C. SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion. Biochem J. 2020;477(19):3803\u201318.","journal-title":"Biochem J"},{"issue":"18","key":"15911_CR33","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1093\/nar\/gkw549","volume":"44","author":"N Liu","year":"2016","unstructured":"Liu N, Ding D, Hao W, Yang F, Wu X, Wang M, et al. hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor. Nucleic Acids Res. 2016;44(18):8693\u2013703.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15911_CR34","doi-asserted-by":"publisher","first-page":"e08673","DOI":"10.1016\/j.heliyon.2021.e08673","volume":"8","author":"RR Prasad","year":"2022","unstructured":"Prasad RR, Mishra DK, Kumar M, Yadava PK. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation. Heliyon. 2022;8(1):e08673.","journal-title":"Heliyon"},{"issue":"1","key":"15911_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13578-022-00896-2","volume":"12","author":"A Meeser","year":"2022","unstructured":"Meeser A, Bartenhagen C, Werr L, Hellmann AM, Kahlert Y, Hemstedt N, et al. Reliable assessment of telomere maintenance mechanisms in neuroblastoma. Cell Biosci. 2022;12(1):160.","journal-title":"Cell Biosci"},{"issue":"12","key":"15911_CR36","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1158\/0008-5472.CAN-19-3068","volume":"80","author":"B Koneru","year":"2020","unstructured":"Koneru B, Lopez G, Farooqi A, Conkrite KL, Nguyen TH, Macha SJ, et al. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma. Cancer Res. 2020;80(12):2663\u201375.","journal-title":"Cancer Res"},{"issue":"5","key":"15911_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s13402-022-00702-8","volume":"45","author":"J Fischer-Mertens","year":"2022","unstructured":"Fischer-Mertens J, Otte F, Roderwieser A, Rosswog C, Kahlert Y, Werr L, et al. Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models. Cell Oncol (Dordr). 2022;45(5):991\u20131003.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"15911_CR38","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1038\/s41598-017-09494-6","volume":"7","author":"I Gamper","year":"2017","unstructured":"Gamper I, Burkhart DL, Bywater MJ, Garcia D, Wilson CH, Kreuzaler PA, et al. Determination of the physiological and pathological roles of E2F3 in adult tissues. Sci Rep. 2017;7(1):9932.","journal-title":"Sci Rep"},{"issue":"1","key":"15911_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12887-022-03424-w","volume":"22","author":"H Wang","year":"2022","unstructured":"Wang H, Wang X, Xu L, Zhang J. Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts. BMC Pediatr. 2022;22(1):376.","journal-title":"BMC Pediatr"},{"key":"15911_CR40","doi-asserted-by":"crossref","unstructured":"De Rosa P, Severi F, Zadran SK, Russo M, Aloisi S, Rigamonti A et al. MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4\/6 Inhibitors\u2019 Efficacy in Neuroblastoma Cells. Int J Mol Sci. 2023;24(6):5408.","DOI":"10.3390\/ijms24065408"},{"issue":"23","key":"15911_CR41","doi-asserted-by":"publisher","first-page":"e2420011122","DOI":"10.1073\/pnas.2420011122","volume":"122","author":"R Pandher","year":"2025","unstructured":"Pandher R, Xue C, Gamble LD, Milazzo G, Di Giacomo S, Murray J, et al. The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response. Proc Natl Acad Sci U S A. 2025;122(23):e2420011122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"15911_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41420-022-00912-x","volume":"8","author":"R Pan","year":"2022","unstructured":"Pan R, Zhang Z, Jia H, Ma J, Wu C, Xue P, et al. CAMTA1-PPP3CA-NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin. Cell Death Discov. 2022;8(1):129.","journal-title":"Cell Death Discov"},{"issue":"8","key":"15911_CR43","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1158\/0008-5472.CAN-10-3014","volume":"71","author":"KO Henrich","year":"2011","unstructured":"Henrich KO, Bauer T, Schulte J, Ehemann V, Deubzer H, Gogolin S, et al. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells. Cancer Res. 2011;71(8):3142\u201351.","journal-title":"Cancer Res"},{"key":"15911_CR44","doi-asserted-by":"publisher","first-page":"153374","DOI":"10.1016\/j.prp.2021.153374","volume":"219","author":"J Xu","year":"2021","unstructured":"Xu J, Jia Q, Zhang Y, Yuan Y, Xu T, Yu K, et al. Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer. Pathol Res Pract. 2021;219:153374.","journal-title":"Pathol Res Pract"},{"issue":"6","key":"15911_CR45","first-page":"2777","volume":"42","author":"H Huo","year":"2019","unstructured":"Huo H, Ye X, Yang H, Li Q, Jiang Y. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer. Oncol Rep. 2019;42(6):2777\u201387.","journal-title":"Oncol Rep"},{"issue":"8","key":"15911_CR46","doi-asserted-by":"publisher","first-page":"102177","DOI":"10.1016\/j.jbc.2022.102177","volume":"298","author":"P Gupta","year":"2022","unstructured":"Gupta P, Jindal A, Ahuja G, Jayadeva, Sengupta D. A new deep learning technique reveals the exclusive functional contributions of individual cancer mutations. J Biol Chem. 2022;298(8):102177.","journal-title":"J Biol Chem"},{"issue":"1","key":"15911_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-023-01931-7","volume":"23","author":"X Su","year":"2024","unstructured":"Su X, Liang C, Chen R, Duan S. Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators. Mol Cancer. 2024;23(1):13.","journal-title":"Mol Cancer"},{"issue":"1","key":"15911_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41419-026-08422-9","volume":"17","author":"C Chen","year":"2026","unstructured":"Chen C, Cai D, Liu X, Zheng Y, Huang X, Chen D, et al. Lactylation of SLC26A3 in the acidic tumor microenvironment promotes malignant progression of colorectal carcinoma. Cell Death Dis. 2026;17(1):164.","journal-title":"Cell Death Dis"},{"issue":"2","key":"15911_CR49","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.apsb.2021.06.009","volume":"12","author":"T Su","year":"2022","unstructured":"Su T, Huang S, Zhang Y, Guo Y, Zhang S, Guan J, et al. miR-7\/TGF-\u03b22 axis sustains acidic tumor microenvironment-induced lung cancer metastasis. Acta Pharm Sin B. 2022;12(2):821\u201337.","journal-title":"Acta Pharm Sin B"},{"key":"15911_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2020.11.014","volume":"144","author":"J Wienke","year":"2021","unstructured":"Wienke J, Dierselhuis MP, Tytgat GAM, K\u00fcnkele A, Nierkens S, Molenaar JJ. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. Eur J Cancer. 2021;144:123\u201350.","journal-title":"Eur J Cancer"},{"key":"15911_CR51","doi-asserted-by":"publisher","first-page":"578770","DOI":"10.3389\/fcell.2020.578770","volume":"8","author":"M Phimmachanh","year":"2020","unstructured":"Phimmachanh M, Han JZR, O\u2019Donnell YEI, Latham SL, Croucher DR. Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma. Front Cell Dev Biol. 2020;8:578770.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"15911_CR52","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-024-03180-y","volume":"43","author":"P Tempora","year":"2024","unstructured":"Tempora P, D\u2019Amico S, Gragera P, Damiani V, Krol K, Scaldaferri V, et al. Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma. J Exp Clin Cancer Res. 2024;43(1):292.","journal-title":"J Exp Clin Cancer Res"},{"key":"15911_CR53","doi-asserted-by":"crossref","unstructured":"Cornel AM, Dunnebach E, Hofman DA, Das S, Sengupta S, van den Ham F et al. Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch. J Immunother Cancer. 2022;10(12):e005002.","DOI":"10.1136\/jitc-2022-005002"},{"issue":"21","key":"15911_CR54","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1158\/1078-0432.CCR-20-5017","volume":"27","author":"ET Roussos Torres","year":"2021","unstructured":"Roussos Torres ET, Rafie C, Wang C, Lim D, Brufsky A, LoRusso P, et al. Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844). Clin Cancer Res. 2021;27(21):5828\u201337.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"15911_CR55","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1038\/s41467-021-25332-w","volume":"12","author":"L Ny","year":"2021","unstructured":"Ny L, Jespersen H, Karlsson J, Als\u00e9n S, Filges S, All-Eriksson C, et al. The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma. Nat Commun. 2021;12(1):5155.","journal-title":"Nat Commun"},{"issue":"3","key":"15911_CR56","doi-asserted-by":"publisher","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8(3):eabi6696.","journal-title":"Sci Adv"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15911-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:05:10Z","timestamp":1778191510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15911-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15911"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15911-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were approved by the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (Approval No. E20210027). Written informed consent was obtained from the legal guardians or next of kin of all participants in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"581"}}